Wahl Bryan
SEC insider (Form 3/4/5 filer). CIK 0001841401. General Counsel at Tarsus Pharmaceuticals, Inc. (TARS). 12 reported Form 4/5 transactions since Sep 2024; latest on Mar 19, 2026. Located in IRVINE, CA.
Companies Wahl Bryan has filed insider reports for
- Tarsus Pharmaceuticals, Inc. (TARS): Officer, General Counsel
Wahl Bryan
CIK: 0001841401
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Tarsus Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Mar 19, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect4.2K shares at avg. $67.00$283K - Mar 18, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect4.1K shares at avg. $68.71$283K - Mar 17, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect4.1K shares at avg. $69.42$284K - Mar 15, 2026TARS
Tarsus Pharmaceuticals, Inc.
ExerciseDirect24.2K shares- - Mar 5, 2026TARS
Tarsus Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
17.2K shares- - Mar 5, 2026TARS
Tarsus Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
27.3K shares- - Mar 20, 2025TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect3.1K shares at avg. $50.11$155K - Mar 19, 2025TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect3.3K shares at avg. $47.40$155K - Mar 18, 2025TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect3.3K shares at avg. $46.29$155K - Mar 15, 2025TARS
Tarsus Pharmaceuticals, Inc.
ExerciseDirect19.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 19, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 4,231 | $67.00 | $283,477 | Direct |
| Mar 18, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 4,125 | $68.71 | $283,429 | Direct |
| Mar 17, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 4,084 | $69.42 | $283,511 | Direct |
| Mar 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Exercise | 24,236 | - | $0 | Direct |
| Mar 5, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Award Restricted Stock Units | 17,161 | - | - | Direct |
| Mar 5, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 27,310 | - | - | Direct |
| Mar 20, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 3,084 | $50.11 | $154,539 | Direct |
| Mar 19, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 3,261 | $47.40 | $154,571 | Direct |
| Mar 18, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 3,341 | $46.29 | $154,655 | Direct |
| Mar 15, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Exercise | 19,213 | - | - | Direct |
1-10 of 12 transactions